- Report
- September 2023
- 150 Pages
Global
From €4347EUR$4,500USD£3,717GBP
- Report
- March 2024
- 193 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- January 2024
- 150 Pages
Global
From €5747EUR$5,950USD£4,915GBP
- Report
- December 2023
- 200 Pages
Global
From €3864EUR$4,000USD£3,304GBP
- Report
- May 2024
- 96 Pages
Global
From €5409EUR$5,600USD£4,626GBP
- Report
- July 2023
- 156 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- January 2024
- 156 Pages
Global
From €3654EUR$3,783USD£3,124GBP
€4299EUR$4,450USD£3,676GBP
- Report
- May 2024
- 50 Pages
Global
From €2560EUR$2,650USD£2,189GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1932EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1207EUR$1,250USD£1,032GBP
- Report
- March 2024
- 180 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 150 Pages
Global
From €5747EUR$5,950USD£4,915GBP
- Report
- March 2024
- 188 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 250 Pages
Global
From €2598EUR$2,690USD£2,222GBP
- Report
- May 2024
- 898 Pages
Global
From €5409EUR$5,600USD£4,626GBP
- Report
- February 2024
- 110 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 114 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 111 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2415EUR$2,500USD£2,065GBP
Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more